Candriam Equities L Oncology Impact celebrates its first year: time for a progress update
Candriam Equities L Oncology Impact celebrates its first year: time for a progress update
Oncology has made more progress over the past 15 years than it did during the whole of the 20th century.
Our strategy celebrates its one year anniversary
With almost 10 million deaths recorded in 2018 and tens of millions of sufferers diagnosed, cancer remains the second-leading cause of death globally. The fight against cancer is everyone’s business.
Over the past year, Candriam has enabled you to join the fight for life by investing in companies which are involved in combatting and preventing cancer.
The fund celebrates its one year anniversary today. Time for our first annual update:
The two fund managers, Rudi Van den Eynde, Head of Thematic Global investments, and Servaas Michielssens, Senior Biotechnology Analyst, answer your questions.
Candriam Equities L Oncology Impact souffle sa première bougie, l’heure d’un premier bilan.prévention et ses conséquences.